Research ArticleLaboratory Studies
Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy
Uwe Haberkorn, Maria Reinhardt, Ludwig G. Strauss, Franz Oberdorfer, Martin R. Berger, Annette Altmann, Reinhard Wallich, Antonia Dimitrakopoulou and Gerhard van Kaick
Journal of Nuclear Medicine November 1992, 33 (11) 1981-1987;
Uwe Haberkorn
Maria Reinhardt
Ludwig G. Strauss
Franz Oberdorfer
Martin R. Berger
Annette Altmann
Reinhard Wallich
Antonia Dimitrakopoulou


This is a PDF-only article. The first page of the PDF of this article appears above.
In this issue
Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy
Uwe Haberkorn, Maria Reinhardt, Ludwig G. Strauss, Franz Oberdorfer, Martin R. Berger, Annette Altmann, Reinhard Wallich, Antonia Dimitrakopoulou, Gerhard van Kaick
Journal of Nuclear Medicine Nov 1992, 33 (11) 1981-1987;
Metabolic Design of Combination Therapy: Use of Enhanced Fluorodeoxyglucose Uptake Caused by Chemotherapy
Uwe Haberkorn, Maria Reinhardt, Ludwig G. Strauss, Franz Oberdorfer, Martin R. Berger, Annette Altmann, Reinhard Wallich, Antonia Dimitrakopoulou, Gerhard van Kaick
Journal of Nuclear Medicine Nov 1992, 33 (11) 1981-1987;
Jump to section
Related Articles
- No related articles found.
Cited By...
- Treatment of Breast Tumor Cells In Vitro with the Mitochondrial Membrane Potential Dissipater Valinomycin Increases 18F-FDG Incorporation
- Assessment of Treatment Response by Autoradiography with 14C-Aminocyclopentane Carboxylic Acid, 67Ga-DTPA, and 18F-FDG in a Herpes Simplex Virus Thymidine Kinase/Ganciclovir Brain Tumor Model
- 2-[18F]Fluoro-2-deoxyglucose and Glucose Uptake in Malignant Gliomas before and after Radiotherapy: Correlation with Outcome